Age-related pseudocapillarization of the human liver

Journal of Pathology

Volumn 200, Issue 1, 2003, Pages 112-117

  McLean, Allan J ^a,b   Cogger, Victoria C ^c   Chong, Guan C ^b   Warren, Alessandra ^c   Markus, Astrid M A ^a   Dahlstrom, Jane E ^b   Le Couteur, David G ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ageing; Defenestration; Electron microscopy; Hepatic sinusoid; Immunohistochemistry; Liver; Pseudocapillarization

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGE DISTRIBUTION; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; BASEMENT MEMBRANE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; LIVER FUNCTION; LIVER SINUSOID; MAJOR CLINICAL STUDY; MORPHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NEUROTOXICITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMIC DISEASE; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; AGED; AGED, 80 AND OVER; AGING; CAPILLARIES; COLLAGEN; ENDOTHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MICROSCOPY, ELECTRON; MIDDLE AGED;

EID: 0037986813     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1328     Document Type: Article

References (15)

1. Le Couteur DG, McLean AJ. The aging liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998; 34: 359-373.
2. Le Couteur DG, Muller M, Yang MC, Mellick GD, McLean AJ. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health 2002; 17: 51-65.
3. Yang MC, McLean AJ, Le Couteur DG. Age-related alteration in hepatic disposition of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pesticides. Pharmacol Toxicol 2002; 90: 203-207.
4. Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002; 359: 1612-1615.
5. Schmucker DL. Aging and the liver: an update. J Gerontol 1998; 53A: B315-B320.
6. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OFW. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
7. Jansen PL. Liver disease in the elderly. Best Pract Res Clin Gastroenterol 2002; 16: 149-158.
8. Le Couteur DG, Cogger VC, Markus AM, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001; 33: 537-543.
9. Fenvyes D, Gariepy L, Villeneuve JP. Clearance by the liver in cirrhosis: I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat. Hepatology 1993; 17: 301-306.
10. Muller AM, Skrzynski C, Nesslinger M, Skipka G, Muller KM. Correlation of age with in vivo expression of endothelial markers. Exp Gerontol 2002; 37: 713-719.
11. Lipman RD, Dallal GE, Bronson RT. Lesion biomarkers of aging in the B6C3F1 hybrid mice. J Gerontol 1999; 54A: B466-B477.
12. Harvey PJ, Le Couteur DG, McLean AJ. Hepatic oxygenation supplementation as therapy in cirrhotic liver disease. Gastroenterology 1999; 117: 1025-1029.
13. Le Couteur DG, Hickey H, Harvey P, Gready J, McLean AJ. Hepatic artery flow and propranolol metabolism in the perfused cirrhotic rat liver. J Pharmacol Exp Ther 1999; 289: 1553-1558.
14. McLean AJ, Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet 1991; 21: 42-69.
15. Fraser R, Dobbs BR, Rogers GW. Lipoproteins and the liver sieve: the role of fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995; 21: 863-874.